STAA: STAAR Surgical Co Projected Price to Earnings

Brandmark of STAAR Surgical Company (STAA)

Stable demand for implants is driven by extensive physician training, which creates a resilient financial foundation. The forward P/E ratio of STAAR Surgical Company (STAA) demonstrates a consolidation of market expectations, where 45.10 serves as the final level mark. Innovative lenses are rapidly displacing laser vision correction and capturing the global market. Technological leadership in this niche allows STAAR Surgical Company (STAA) to exercise pricing power by setting premium prices for its unique product.

STAA - STAAR Surgical Market Cap to Projected Earnings over the range 07/04/2022 - 11/16/2026

Analytical breakdowns and data insights for company STAAR Surgical (STAA)

- stock value and consensus price forecast:
Summary company analysis:STAA STAAR Surgical Corp
Signature product of staar.com

STAAR Surgical Company (STAA) expansion into the Asian refractive surgery market is reflected in the company's forward P/E multiple. This indicator compares the current market share price with expected annual net income. The calculation allows for an assessment of how much an investor is willing to pay per unit of the business's future earnings. The upward trend signals market optimism but increases the risk of a correction. The asset is categorized as a growth stock.

Direct competitors

Future Price to Earnings Intuitive Surgical Inc (ISRG)|DHR (Danaher Corp) - Future Price to Earnings Multiple|Forward P/E Multiple BDX (bd.com)|Market Cap to Projected Earnings steris.com (STE)|WST - Future Price to Earnings|BAX (Baxter International Inc.) - Price to Future Earnings Ratio|Masimo Corporation (MASI) - Future Price to Earnings|Price to Future Earnings Ratio STVN|Projected Price to Earnings TFX|Merit Medical (MMSI) - Market Cap to Projected Earnings|Projected Price to Earnings NVST (Envista Holdings)|Market Cap to Future Earnings Ratio ICUI|Future Price to Earnings Dentsply XRAY|Future Price to Earnings Multiple LMAT|ATRC: Projected Price to Earnings|NAGE - Forward P/E Multiple|ZimVie Inc (ZIMV) - Future Price to Earnings|Projected Price to Earnings AngioDynamics|CERS (cerus.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Teknova Inc TKNO|Future Price to Earnings Monogram Orthopedics (MGRM)|Sharps Tech - Price to Future Earnings Ratio|InfuSystem Holdings, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio UTMD (Utah Medical Products Inc.)|KRMD - Future Price to Earnings|Market Cap to Projected Earnings Nyxoah S.A NYXH|microbotmedical.com (MBOT) - Future Price to Earnings|Price to Expected Earnings Ratio PDEX (pro-dex.com)|ZTEK (Zentek Corp) - Forward P/E Multiple|Future Price to Earnings ELUT|Future Price to Earnings Milestone Scientific Corp (MLSS)|NEXGEL, Inc - Price to Future Earnings Ratio|Forward P/E Multiple RVP (Retractable Technologies Inc.)|Harvard Bioscience, Inc. - Future Price to Earnings|FEMY - Future Price to Earnings|MHUA - Forward P/E Multiple|POAI: Forward P/E Multiple|Price to Future Earnings Ratio CJMB|Projected Price to Earnings ATRI|Projected Price to Earnings Ratio NeuroMetrix NURO